Аннотация:Oral administration of Rhodiolae rosea extract to a small group of patents (n = 12) with superficial bladder carcinoma (T1G1-2) improved the characteristics of the urothelial thissue integration, parameters of leukocyte integrines and T-cell immunity. The average frequency of relapses for these patients has been found to fall twice, though statistical differences were not significant.